× Business
TelecomHealthcareDigital MarketingERPRetailMedia and EntertainmentOil and GasFood and BeveragesMarketing and AdvertisingBanking and InsuranceMetals and MiningLegalComplianceCryptocurrency
Big DataCloudIT ServiceSoftwareMobileSecurityNetworkingStorageCyber SecuritySAPData AnalysisloTBio TechQuality AssuranceEducationE-commerceGaming and VFXArtificial Intelligence
Cisco DATABASE Google IBM Juniper Microsoft M2M Oracle Red hat Saas SYMANTEC
CEO ReviewCMO ReviewCFO ReviewCompany Review
Startups Opinion Yearbook Readers Speak Contact Us

"Genetic testing is the future of healthcare," says Jonathan Edelheit, CEO of GHR


In its mission to improve the health status of the employees, Wamberg Genomic Advisors (WGA) has made a partnership with the Global Healthcare Resources (GHR) that delivers Genomic testing to its workforce thus educating them more with the health issues associated and making a more productive workforce free from any kind of health issues. "Genetic testing is the future of healthcare," said Jonathan Edelheit, CEO of GHR. This partnership aims at improving the total health status of all the employees by educating insurance professionals and employers about the potential of genetic testing. Genetic testing promises to revolutionize healthcare industry. WGA aims at delivering genomic products and services to policy holders of life insurance companies, employers and their employees as well.

The initiative is expected to eliminate many of the health crises that employers face in this modern world. Apart from the detailed information on the current health status, it gives employers an opportunity to tailor a personalized health plan. "We are thrilled to announce this partnership," said Tom Wamberg, CEO of WGA. "By working with GHR to enter the employer and insurance markets, we can not only help individuals unlock the potential of their health, we can further the power of genetic tests. As more people have their genetics sequenced, the industry as a whole will be able to provide additional insights and more accurate predictions as we better understand the genetic components of disease."  With the partnership they are trying to bring a technology that can improve the health decisions of its employees and ensure them a longer life.